Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial-Reference-Cited by-同舟云学术

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

Published:2005-11 Issue:9500 Volume:366 Page:1849-1861
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Diabetes and heart disease;Barrett-Connor,1985

2. Diabetes and other risk factors and the 12-year cardiovascular mortality for men screened for the Multiple Risk Factor Intervention Trial;Stamler;Diabetes Care,1993

3. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study;Zuanetti;J Am Coll Cardiol,1993

4. Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial;Keech;Diabetes Care,2003

5. Serum lipids and lipoproteins in middle aged non-insulin dependent diabetics;Laakso;Atherosclerosis,1985

Cited by 2816 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to retention hypothesis as a source of targets for arterial wall-directed therapies to prevent atherosclerosis: A critical review;Atherosclerosis;2024-10

2. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases;Metabolism;2024-10

3. Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia;New England Journal of Medicine;2024-09-12

4. Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia;New England Journal of Medicine;2024-09-12

5. Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large‐scale claim database analysis of Japan;Journal of Diabetes Investigation;2024-09-05